or Try an Advanced Search...

    Vascular Disease Stocks List

    Symbol Grade Name % Change
    NVNO F enVVeno Medical Corporation -4.76
    IRWD F Ironwood Pharmaceuticals, Inc. -2.43
    KOD F Kodiak Sciences Inc -0.38
    OCUP F Ocuphire Pharma, Inc. -3.82
    SMLR F Semler Scientific, Inc. -4.54
    FLGT F Fulgent Genetics, Inc. -3.04
    NBIX F Neurocrine Biosciences, Inc. -0.93
    AMRN F Amarin Corporation plc -1.10
    BCDA F BioCardia, Inc. -4.49
    REGN D Regeneron Pharmaceuticals, Inc. -0.41
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Medical Appliances & Equipment Medical Devices Medical Instruments & Supplies
    Related Stock Lists: Cardiovascular Disease Angiogenesis Biotechnology Diabetes Inflammation Medicine Ophthalmology Organ Systems Angiology Biopharmaceutical Bone Cholesterol Clinical Development Diabetic Retinopathy Disorders Heart Disease Lipoprotein Macular Degeneration Macular Edema Pain

    Related ETFs - A few ETFs which own one or more of the above listed Vascular Disease stocks.

    Symbol Grade Name Weight
    BBH D Market Vectors Biotech ETF 19.76
    IBBQ D Invesco Nasdaq Biotechnology ETF 18.98
    IBB D iShares Nasdaq Biotechnology Index Fund 17.69
    IHI C iShares U.S. Medical Devices ETF 16.67
    PJP B PowerShares Dynamic Pharmaceuticals 14.12
    View all Vascular Disease ETFs...
    Compare ETFs
    Compare BBH to IHI Compare IBB to PJP Compare IBBQ to PJP

        Vascular Disease Stocks Recent News

        Date Stock Title
        Oct 1 AMRN Amarin Announces Two Upcoming Investor Events
        Sep 30 NBIX Neurocrine touts long-term effectiveness of Ingrezza for Huntington's disease chorea
        Sep 30 REGN Sanofi, Regeneron's Dupixent Gets FDA Approval for COPD
        Sep 30 SMLR Semler Scientific (NASDAQ:SMLR) shareholders have endured a 81% loss from investing in the stock three years ago
        Sep 30 NBIX Neurocrine Biosciences Presents Interim Data Demonstrating Robust and Sustained Improvements in Chorea Associated With Huntington's Disease Through Week 104 Irrespective of Antipsychotic Use
        Sep 30 OCUP Ocuphire Pharma Announces Publication of Full Phase 3 Results of Phentolamine Ophthalmic Solution 0.75% for Pharmacologically-Induced Mydriasis in Ophthalmology
        Sep 29 REGN Regeneron Pharma, Super Micro Computer And Global Payments Are Among Top 10 Large Cap Losers Last Week (Sept 23-Sept 27): Are The Others In Your Portfolio?
        Sep 29 REGN Novo Nordisk's Ozempic, Regeneron/Sanofi's Dupixent set to advance in top drug sales
        Sep 29 REGN Regeneron: Long-Term Defensive Investment
        Sep 28 REGN Regeneron, Sanofi announce Dupixent approval in China for patients with COPD
        Sep 28 REGN Wall Street Breakfast: What Moved Markets
        Sep 28 REGN Jim Cramer on Regeneron Pharmaceuticals Inc. (REGN): ‘Leerink Analysts Downgraded Regeneron To A Market Perform Hold After A Negative Eylea 2mg Biosimilar Preliminary Injunction Ruling’
        Sep 27 REGN Regeneron-Sanofi Drug Wins FDA Approval To Treat COPD
        Sep 27 REGN Regeneron Shares Head for Worst Month Since 2019 on Legal Ruling
        Sep 27 REGN FDA greenlights Regeneron’s Dupixent for the treatment of COPD
        Sep 27 NVNO Crude Oil Rises; Onconetix Shares Spike Higher
        Sep 27 REGN Regeneron/ Sanofi granted FDA label expansion for Dupixent in COPD
        Sep 27 REGN Sanofi/Regeneron’s Dupixent set to dominate COPD biologics market following FDA approval
        Sep 27 REGN Regeneron, Sanofi Get FDA OK for Dupixent to Treat COPD
        Sep 27 REGN Sanofi, Regeneron get additional Chinese approval for Dupixent
        Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Medical Appliances & Equipment Medical Devices Medical Instruments & Supplies
        Related Stock Lists: Cardiovascular Disease Inflammation Medicine Biopharmaceutical Diabetes Hypertension Infectious Diseases Macular Degeneration Pain S&P 500 Angiogenesis Antibodies Biotechnology Bone Cholesterol Clinical Development Disorders Hematology Human Monoclonal Antibodies Immunology
        Vascular Disease

        Vascular disease is a term used to describe any condition that affects the circulatory system, including the arteries, veins, and capillaries. It can be caused by a variety of factors, including high blood pressure, high cholesterol, smoking, diabetes, and obesity. Vascular diseases can lead to serious health complications, such as stroke, heart attack, and peripheral artery disease.

        Browse All Tags